The Progeria Market is gaining attention as research into rare genetic disorders continues to advance. Growing awareness, improved genetic diagnosis, and increasing investment in orphan drug development are supporting market growth. The introduction of targeted therapies and ongoing clinical research are expected to expand treatment options and improve outcomes for patients affected b... https://www.delveinsight.com/report-store/hutchinson-gilford-progeria-syndrome-hgps-market?utm_source=report&utm_medium=promotion&utm_campaign=kkpr